INCR

5.91% 0.0547

Handel nachbörslich: .98

Intercure Ltd (INCR)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Intercure Ltd Stock (INCR) Company Profile

Intercure Ltd

Healthcare (1077)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

INCR's Discussions on Twitter

Compare INCR vs TAK, HLN, TEVA, ZTS, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
INCR Intercure Ltd	0.98	51.61M	117.93M	5.00M	-12.91M	0.1314
TAK Takeda Pharmaceutical Co Adr	17.45	55.69B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	10.03	43.77B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	35.36	36.19B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	72.66	32.25B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	538.84	26.29B	3.17B	1.29B	1.01B	27.09

Intercure Ltd Stock (INCR) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2022-05-18	Hochstufung	Canaccord Genuity	Speculative Buy → Buy

Intercure Ltd Aktie (INCR) Neueste Nachrichten

Finanzdaten der Intercure Ltd-Aktie (INCR)

Intercure Ltd (INCR)

Intercure Ltd Stock (INCR) Company Profile

Compare INCR vs TAK, HLN, TEVA, ZTS, UTHR

Intercure Ltd Stock (INCR) Upgrades & Downgrades

Intercure Ltd Aktie (INCR) Neueste Nachrichten

InterCure Ltd. Revenue Breakdown – TASE:INCR - TradingView

InterCure Ltd (INCR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

InterCure Ltd (INCR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

InterCure Ltd (INCR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

InterCure Ltd (INCR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

InterCure Ltd (INCR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

InterCure Ltd (INCR) Income Statement - TradingKey

INCR|InterCure Ltd|Price:0.939|Chg%:-0.020 - TradingKey

INCR|InterCure Ltd|Price:0.927|Chg%:+0.025 - TradingKey

InterCure Ltd (INCR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

What Is Driving InterCure (NASDAQ:INCR) on the Nasdaq? - Kalkine Media

Intercure Ltd. (INCR) Q2 2023 Earnings: EPS Beats Estimates by 28.7% as Stock GainsRevenue Growth Outlook - dars.gov.et

InterCure (INCR) seeks approval for 5-for-1 reverse share split - Stock Titan

InterCure Calls August 12 EGM to Approve 5‑for‑1 Reverse Share Split - TipRanks

Alexander Rabinovich Net Worth (2026) - GuruFocus

Lennie Grinbaum Michelson Net Worth (2026) - GuruFocus

Price to book forward of Intercure Ltd. – NASDAQ:INCR - TradingView

ETFs Investing in InterCure Ltd. Stocks - TradingView

Intercure Ltd. (INCR) Slides 3% as Support at $0.90 Comes Into FocusFibonacci Entry Signals - dars.gov.et

InterCure Ltd. Actuals & Estimates (TASE:INCR) - TradingView

Price to earnings forward of InterCure Ltd. – TASE:INCR - TradingView

InterCure Ltd. Actuals & Estimates (BOATS:INCR) - TradingView

Intercure (INCR) Sees Modest Decline, Tests Key Support Near $1.00NHNL Divergence - dars.gov.et

Price to sales forward of InterCure Ltd. – TASE:INCR - TradingView

Enterprise value to EBITDA forward of InterCure Ltd. – TASE:INCR - TradingView

Intercure Ltd. (INCR) Q2 2023 Earnings: EPS Beats Estimates by 28.7% Amid Uncertain Revenue PictureEnergy Earnings Report - dars.gov.et

InterCure Secures NIS 22 Million in Private Placement Financing Led by Leading Pharma-Focused Hedge Funds - Sahm

InterCure secures $7.4M funding commitment, may rise to $18.6M - Investing.com UK

InterCure Ltd. announced that it expects to receive ILS 21.711643 million in funding from Bennu Pharma Fund Ltd and other investors. - marketscreener.com

InterCure Secures NIS 22 Million Private Placement to Fund Global Medical Cannabis Expansion - TipRanks

InterCure secures $7.4M funding commitment, may rise to $18.6M By Investing.com - Investing.com South Africa

InterCure (NASDAQ: INCR) lines up NIS 22–54 million private placement funding - Stock Titan

InterCure raises NIS 22M in private placement t... - Pluang

InterCure Ltd (INCR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

InterCure Ltd (INCR) Institutional Confidence - TradingKey

InterCure Ltd (INCR) Valuation: PE, PB & Fair Value Analysis - TradingKey

INCR Q2 2023 Earnings: EPS Surpasses Estimates on Operational StrengthEarnings Sentiment Score - Bölüm Sonu Canavarı

InterCure Advances Global Push With Botanico Acquisition Tranche and U.S. Strategy Review - The Globe and Mail

InterCure completes Botanico acquisition and expands into U.S. medical cannabis - MMJDaily

InterCure Initiates Review of US Medical Cannabis Opportunities Following Federal Rescheduling - Cannabis Business Times

InterCure completes first tranche of Botanico acquisition By Investing.com - Investing.com South Africa

InterCure Ltd. Completes First Tranche of Botanico Acquisition to Enhance International Medical Cannabis Platform - Moomoo

InterCure (NASDAQ: INCR) advances Botanico deal and eyes U.S. medical cannabis - Stock Titan

InterCure Initiates Strategic Review of U.S. Medical - GlobeNewswire

U.S. cannabis shift prompts InterCure rethink and new launches in Germany - Stock Titan

InterCure Ltd. completed the acquisition of 50% stake in Botanico Ltd. - marketscreener.com

Intercure Ltd. (INCR) Holds Near Support as Modest Gains Signal Stabilization AttemptRevenue Weighted - newsline.com

INCR Q2 2023 Earnings: EPS Surges Past Estimates by Nearly 29%, Yet Stock Sheds ValueSegment Revenue Breakdown - newsline.com

Intercure Ltd. (INCR) Q2 2023 Earnings: EPS Beats Estimates by 28.68% Amidst Revenue Uncertainty - dars.gov.et

INCR Q2 2023 Earnings: EPS Surpasses Estimates by 28.7%, Driving Stock HigherPositive Surprise Momentum - newsline.com

INCR Q2 2023 Earnings: EPS Surges Past Estimates, Stock Declines Amid Broader Market HeadwindsWeak Earnings Momentum - dars.gov.et

Finanzdaten der Intercure Ltd-Aktie (INCR)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie INCR